계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Respicardia
company
About
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $27M
- Industries
- Health Care,Medical Device,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$106.50M
Respicardia has raised a total of
$106.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2017 | Series Unknown | $58.50M | 1 | — | — | Detail |
| Aug 25, 2010 | Series C | $27M | 1 | — | — | Detail |
| Oct 17, 2008 | Series B | $21M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Respicardia is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
